Contemporary perspectives on the pathophysiology of Meniere's disease: Implications for treatment

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 18, Issue 5, 2010, Pages 392-398

  Semaan, Maroun T ^a   Megerian, Cliff A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

cochlear apoptosis; endolymphatic fluid homeostasis; endolymphatic hydrops; Meniere's disease; neurotoxicity

Indexed keywords

ACETAZOLAMIDE; AMILORIDE; AQUAPORIN; BUMETANIDE; CHLOROTHIAZIDE; DEXAMETHASONE; OUABAIN; STEROID;

ALLERGY; APOPTOSIS; AUTOIMMUNE DISEASE; DISEASE SEVERITY; ELECTRICAL POTENTIAL PARAMETERS; ELECTROCOCHLEOGRAPHY; ENDOLYMPH; ENDOLYMPHATIC SAC; EPISODIC VERTIGO; EXCITOTOXICITY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEARING LOSS; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HYPOPLASIA; INJURY; INNER EAR DISEASE; ION TRANSPORT; MASTOID; MENIERE DISEASE; NEUROPROTECTION; NONHUMAN; OTOSCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGMOID SINUS; TINNITUS; VESTIBULAR EVOKED MYOGENIC POTENTIAL; VESTIBULE AQUEDUCT;

ADULT; ENDOLYMPHATIC HYDROPS; FEMALE; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED;

EID: 77957811630     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32833d3164     Document Type: Review

References (67)

1. Stahle J, Stahle C, Arenberg IK. Incidence of Meniere's disease. Arch Otolaryngol 1978; 104:99-102.
2. Wladislavosky-Waserman P, Facer GW, Mokri B, et al. Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope 1984; 94:1098-1102.
3. Da Costa SS, de Sousa LC, Piza MR. Meniere's disease: overview, epide-miology, and natural history. Otolaryngol Clin North Am 2002; 35:455-495.
4. Mizukoshi K, Ino H, Ishikawa K, et al. Epidemiological survey of definite cases of Meniere's disease collected by the seventeen members of the Meniere's Disease Research Committee of Japan in 1975-1976. Adv Otorhinolaryngol 1979; 25:106-111.
5. Morrison AW, Bailey ME, Morrison GA. Familial Meniere's disease: clinical and genetic aspects. J Laryngol Otol 2009; 123:29-37.
6. Ménière P. Maladies de l'oreille interne offrant les symptomes de la conges-tion cérébrale apoplectiforme. Gaz Méd de Paris 1861; 16:88.
7. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryn-gology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113: 181-185.
8. House JW, Doherty JK, Fisher LM, et al. Meniere's disease: prevalence of contralateral ear involvement. Otol Neurotol 2006; 27:355-361.
9. Semaan MT, Alagramam KN, Megerian CA. The basic science of Meniere's disease and endolymphatic hydrops. Curr Opin Otolaryngol Head Neck Surg 2005; 13:301-307.
10. Hallpike CS, Cairns H. Observationson the pathology ofMeniere's syndrome (Section of Otology). Proc R Soc Med 1938; 31:1317-1336.
11. Paparella MM, Morizono T, Matsunaga T. Kyoshiro Yamakawa, MD, and temporal bone histopathology of Meniere's patient reported in 1938. Commemoration of the centennial of his birth. Arch Otolaryngol Head Neck Surg 1992; 118:660-662.
12. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syn-drome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005; 26:74-81.
13. Clark SK, Rees TS. Posttraumatic endolymphatic hydrops. Arch Otolaryngol 1977; 103:725-726.
14. Hughes GB, Barna BP, Kinney SE, et al. Autoimmuneendolymphatichydrops: five-year review. Otolaryngol Head Neck Surg 1988; 98:221-225.
15. Paparella MM, Kimberley BP. Pathogenesis of Meniere's disease. J Vestib Res 1990; 1:3-7.
16. Ruckenstein MJ. Autoimmune innereardisease. Curr Opin Otolaryngol Head Neck Surg 2004; 12:426-430.
17. Paparella MM. Pathogenesis of Meniere's disease and Meniere's syndrome. Acta Otolaryngol Suppl 1984; 406:10-25.
18. Fayad JN, Linthicum FH Jr. Temporal bone histopathology case of the month: otosyphilis. Am J Otol 1999; 20:259-260.
19. Lonser RR, Kim HJ, Butman JA, et al. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med 2004; 350:2481-2486.
20. Megerian CA, Semaan MT. Evaluation and management of endolym-phatic sac and duct tumors. Otolaryngol Clin North Am 2007; 40:463-478; viii.
21. Liston SL, Paparella MM, Mancini F, et al. Otosclerosis and endolymphatic hydrops. Laryngoscope 1984; 94:1003-1007.
22. Paparella MM. Mondini's deafness: a review of histopathology. Ann Otol Rhinol Laryngol Suppl 1980; 89:1-10.
23. Hall SF, O'Connor AF, Thakkar CH, et al. Significance of tomography in Meniere's disease: visualization and morphology of the vestibular aqueduct. Laryngoscope 1983; 93:1546-1550.
24. Ikeda M, Sando I. Paravestibular canaliculus in Meniere's disease: a histo-pathological study. Ann Otol Rhinol Laryngol Suppl 1985; 118:11-16. (Pubitemid 16253627)
25. Morrison AW. Anticipation in Meniere's disease. J Laryngol Otol 1995; 109:499-502.
26. Fransen E, Verstreken M, Verhagen WI, et al. High prevalenceof symptomsof Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999; 8:1425-1429.
27. Verstreken M, Declau F, Wuyts FL, et al. Hereditary otovestibular dysfunction and Meniere's disease in a large Belgian family is caused by a missense mutation in the COCH gene. Otol Neurotol 2001; 22:874-881.
28. Derebery MJ. Allergic and immunologic aspects of Meniere's disease. Otolaryngol Head Neck Surg 1996; 114:360-365.
29. Derebery MJ. The role of allergy in Meniere's disease. Otolaryngol Clin North Am 1997; 30:1007-1016.
30. Yazawa Y, Suzuki M, Hanamitsu M, et al. Detection of viral DNA in the endolymphatic sac in Meniere's disease by in situ hybridization. ORL J Otorhinolaryngol Relat Spec 2003; 65:162-168.
31. Birgerson L, Gustavson KH, Stahle J. Familial Meniere's disease: a genetic investigation. Am J Otol 1987; 8:323-326.
32. Verhagen WI, Bom SJ, Fransen E, et al. Hereditarycochleovestibulardysfunc-tion due to a COCH gene mutation (DFNA9): a follow-up study of a family. Clin Otolaryngol Allied Sci 2001; 26:477-483.
33. Morrison AW, Johnson KJ. Genetics (molecular biology) and Meniere's disease. Otolaryngol Clin North Am 2002; 35:497-516.
34. Megerian CA, Semaan MT, Aftab S, et al. A mouse model with postnatal endolymphatic hydrops and hearing loss. Hear Res 2008; 237:90-105.
35. Koo JW, Oh SH, Chang SO, et al. Association of HLA-DR and type II collagen autoimmunity with Meniere's disease. Tissue Antigens 2003; 61:99-103.
36. Lopez-Escamez JA, Vilchez JR, Soto-Varela A, et al. HLA-DRB1 *1101 allele may be associated with bilateral Meniere's disease in southern European population. Otol Neurotol 2007; 28:891-895.
37. Xenellis J, Morrison AW, Mc Clowskey D, et al. HLA antigens in the pathogen-esis of Meniere'sdisease. J Laryngol Otol 1986; 100:21-24.
38. Morrison AW, Mowbray JF, Williamson R, et al. On genetic and environmental factors in Meniere's disease. Am J Otol 1994; 15:35-39.
39. Yoo TJ, Yazawa Y, Tomoda K, et al. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science 1983; 222:65-67.
40. Derebery MJ, Rao VS, Siglock TJ, et al. Meniere's disease: an immune complex-mediated illness? Laryngoscope 1991; 101:225-229.
41. Derebery MJ, Berliner KI. Prevalence of allergy in Meniere's disease. Otolaryngol Head Neck Surg 2000; 123:69-75.
42. Derebery MJ. Allergic management of Meniere's disease: an outcome study. Otolaryngol Head Neck Surg 2000; 122:174-182.
43. Barrs DM. Intratympanic injections of dexamethasone for long-term control of vertigo. Laryngoscope 2004; 114:1910-1914.
44. Boleas-Aguirre MS, Lin FR, Della Santina CC, et al. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol Neurotol 2008; 29:33-38.
45. Salt AN. Regulation of endolymphatic fluid volume. Ann N Y Acad Sci 2001; 942:306-312.
46. Beitz E, Zenner HP, Schultz JE. Aquaporin-mediated fluid regulation in the inner ear. Cell Mol Neurobiol 2003; 23:315-329.
47. Wangemann P. K+ cycling and the endocochlear potential. Hear Res 2002; 165:1-9.
48. Couloigner V, Loiseau A, Sterkers O, et al. Effect of locally applied drugs on the endolymphatic sac potential. Laryngoscope 1998; 108:592-598.
49. Thirlwall AS, Kundu S. Diuretics for Meniere'sdiseaseorsyndrome. Cochrane Database Syst Rev 2006; 3:CD003599.
50. Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere's disease. Otolaryngol Head Neck Surg 1989; 100:6-16.
51. Quaranta A, Marini F, Sallustio V. Long-term outcome of Meniere's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 1998; 3:54-60.
52. Brinson GM, Chen DA, Arriaga MA. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Meniere's disease. Otolaryngol Head Neck Surg 2007; 136:415-421.
53. Kim HH, Wiet RJ, Battista RA. Trends in thediagnosisand the managementof Meniere's disease: results of a survey. Otolaryngol Head Neck Surg 2005; 132:722-726.
54. Van De Water TR, Lallemend F, Eshraghi AA, et al. Caspases, the enemy within, andtheirrole in oxidativestress-induced apoptosisofinnerearsensory cells. Otol Neurotol 2004; 25:627-632.
55. Furness DN, Hulme JA, Lawton DM, et al. Distribution of the glutamate/aspartate transporter GLAST in relation to the afferent synapses of outer hair cells in the guinea pig cochlea. J Assoc Res Otolaryngol 2002; 3:234-247.
56. Matsuda K, Ueda Y, Doi T, et al. Increase in glutamate- aspartatetransporter (GLAST) mRNA during kanamycin-induced cochlear insult in rats. Hear Res 1999; 133:10-16.
57. Urushitani M, Nakamizo T, Inoue R, et al. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J Neurosci Res 2001; 63:377-387.
58. Anne S, Kisley LB, Tajuddin ST, et al. Molecularchanges associated with the endolymphatic hydrops model. Otol Neurotol 2007; 28:834-841.
59. Megerian CA. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Meniere's disease. Laryngo-scope 2005; 115:1525-1535.
60. Momin SR, Melki SJ, Alagramam KN, et al. Spiral ganglion lossoutpaces inner haircell loss in endolymphatic hydrops. Laryngoscope 2010; 120:159-165.
61. Melki SJ, Heddon CM, Frankel JK, et al. Pharmacological protection ofhearing loss in the mouse model ofendolymphatic hydrops. Laryngoscope (in press).
62. Gatland DJ, Billings RJ, Youngs RP, et al. Investigation of the physiological basis of summating potential changes in endolymphatic hydrops. Acta Otolaryngol 1988; 105:218-222.
63. Ge X, Shea JJ Jr. Transtympanic electrocochleography: a 10-year experience. Otol Neurotol 2002; 23:799-805.
64. Kim HH, Kumar A, Battista RA, et al. Electrocochleography in patients with Meniere's disease. Am J Otolaryngol 2005; 26:128-131.
65. Rauch SD, Zhou G, Kujawa SG, et al. Vestibular evoked myogenic potentials show altered tuning in patients with Meniere's disease. Otol Neurotol 2004; 25:333-338.
66. Timmer FC, Zhou G, Guinan JJ, et al. Vestibular evoked myogenic potential (VEMP) in patients with Meniere's disease with drop attacks. Laryngoscope 2006; 116:776-779.
67. Lin MY, Timmer FC, Oriel BS, et al. Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic saccular hydrops. Laryngoscope 2006; 116:987-992.